OHR PHARMACEUTICAL, INC.
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- May 11, 2017 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 343 Total Citation Count
- Jun 07, 1995 Earliest Filing
- 8 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0129,914 Aminosteroids for the Treatment of a PTP1B Associated DiseaseOct 06, 16May 11, 17[C07J]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8716270 Polymorphic and amorphous salt forms of squalamine dilactateJun 23, 11May 06, 14[A61K, C07J]
7981876 Polymorphic and amorphous salt forms of squalamine dilactateApr 25, 06Jul 19, 11[A61K, C07J]
7728157 Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterolsMar 21, 05Jun 01, 10[C07J]
7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disordersDec 11, 00Jul 11, 06[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0265,541 Biodegradable Microcapsules Containing Filling MaterialAbandonedSep 20, 13Sep 24, 15[A61K]
7439234 Method for treating cancer patients undergoing chemotherapyExpiredJun 05, 03Oct 21, 08[A01N]
6962909 Treatment of neovascularization disorders with squalimineExpiredNov 02, 01Nov 08, 05[A61K, C07C]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
